Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TeSLA: Telbivudine + Adefovir vs Lamivudine + Adefovir in Lamivudine-Resistant Hepatitis B
NCT01804387Phase 4Unknown
- Sponsor
- Korea University
- Start
- May 2011
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of telbivudine in Chronic Hepatitis B (CHB), sponsored by Korea University. Status: unknown.
02
Drugs
telbivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01804387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01804387.